Antenatal Steroid Exposure and Neural Control of Blood Pressure

产前类固醇暴露与血压的神经控制

基本信息

  • 批准号:
    8712518
  • 负责人:
  • 金额:
    $ 14.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-08-20 至 2016-01-31
  • 项目状态:
    已结题

项目摘要

Program investigators established that glucocorticoid administration to pregnant ewes at 80 d gestation results in elevated blood pressure in offspring as early as 6 months of age, likely as a result of widespread effects on the renin-angiotensin system (RAS). The changes in the RAS resulting from steroid exposure appear specific to each tissue and differ in males and females, but a shift in favor Ang II over Ang-(1-7) is the overall hypothesis to be explored in the renewal application. Adolescents with antenatal steroid exposure (Project 4) show reduced heart rate variability (HRV) without elevated pressure, suggesting altered autonomic function exists in the young human subjects. In Project 3, we show that baroreflex sensitivity (BRS) for control of heart rate and HRV, important indicators of autonomic control and risk factors for higher target organ damage and increased mortality, are impaired preceding the elevation in blood pressure showing direct parallels between the human subjects and the sheep model of fetal programming. In sheep, the BRS impairments are attenuated or reversed acutely with ATi receptor blockade, supporting a role for exaggerated Ang II effects in exposed animals. Protective effects of Ang-(1-7) were shown to be absent or reduced in exposed animals, contributing to the BRS impairment in both males and females. New preliminary studies reveal the increased contribution of Ang II and loss of Ang-(1-7) for control of BRS within the nucleus tractus solitarius (NTS). We propose that elevated expression of Ang II, or decreased Ang-(1-7) or its receptor in the NTS underlies the autonomic dysfunction predisposing to higher blood pressure and target organ damage following antenatal steroid exposure. Aim 1: is expression of receptors, processing enzymes for Ang II and Ang-(1-7) formation/ metabolism, or peptide levels in the dorsal medulla including NTS and choroid plexus of the 4th ventricle altered in sheep treated antenatally with betamethasone, prior to or coincident with increased blood pressure, renal or cardiac dysfunction (between 6 wks and 6 months post-natal)? Aim 2: is regulation of the BRS shifted towards Ang II in the NTS of exposed sheep at 6 wks of age? Aim 3: will blockade of Ang-(1-7) receptors in brain 4th ventricle of control sheep impair BRS and initiate an increase in pressure to mimic antenatal steroid exposure? Aim 4: will Ang-(1-7) or an ATi antagonist infusion via 4th ventricle correct the impaired BRS, increased blood pressure and renal manifestations of steroid exposure? The primary objective ofthe Administrative Core is to provide overall administrative support to the program.
计划研究人员确定,在80 d妊娠的80 d妊娠时糖皮质激素对怀孕的母羊进行给药会导致后代的血压升高,可能是6个月大,这可能是由于对肾素 - 血管紧张素系统(RAS)的广泛影响而导致的。类固醇暴露引起的RAS的变化似乎特定于每种组织,并且在男性和女性中有所不同,但是在续签应用中探索了Ang II的转变比Ang II相比 - (1-7)。产前类固醇暴露的青少年(项目4)显示心率变异性降低而没有压力升高,表明年轻的人类受试者存在自主功能的改变。在项目3中,我们表明,用于控制心率和HRV的压力反射灵敏度(BRS),自主神经控制的重要指标以及较高的目标器官损害和死亡率增加的风险因素,在血压的升高之前是人类受试者之间直接相似之处的血压升高和胎儿模型的直接相似之处。在绵羊中,BRS损伤被ATI受体阻塞急剧衰减或逆转,这支持了在暴露动物中夸张的ANG II效应的作用。在暴露的动物中,Ang-(1-7)的保护作用被证明不存在或减少,导致男性和女性的BRS损害。新的初步研究揭示了ANG II的贡献和ANG-(1-7)对控制核片内BRS(NTS)内BR的贡献的增加。我们提出,ANG II的表达升高,或者在NTS中降低ANG-(1-7)或其受体的降低是自主神经功能障碍易受性血压和靶心器官损害后,产前类固醇暴露后。目的1:受体的表达,ANG II和ANG的加工酶是(1-7)形成/代谢/代谢或背侧髓质中的肽水平,包括NTS和第四个心室的脉络丛在绵羊治疗,在与β-次甲酮相结合之前,绵羊治疗的绵羊和肾小球均与6个月相结合的6个月(6个月)(肾脏压力)增加了6个月(肾脏)(6个月)。 AIM 2:BRS的调节是否在6周龄裸露的绵羊的NT中转向ANG II? AIM 3:在脑第4个心室中阻断Ang-(1-7)受体会损害BRS,并启动模仿触及类固醇暴露的压力增加吗? AIM 4:通过第四脑室通过第四个心室纠正受损的BR,血压增加和类固醇暴露的肾脏表现,ANG-(1-7)或ATI拮抗剂会纠正吗?行政核心的主要目的是为该计划提供总体行政支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES C. ROSE其他文献

Performance of task functions by A.D.A. dietetic technicians
  • DOI:
    10.1016/s0002-8223(21)39276-8
  • 发表时间:
    1980-06-01
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    JAMES C. ROSE;KATHLEEN ZOLBER;IRMA VYHMEISTER;DAVID ABBEY;KENNETH BURKE
  • 通讯作者:
    KENNETH BURKE

JAMES C. ROSE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES C. ROSE', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    7005940
  • 财政年份:
    2005
  • 资助金额:
    $ 14.92万
  • 项目类别:
Antenatal Steroids Exposure and Adipose Tissue Renin-Angiotensin-System Function
产前类固醇暴露与脂肪组织肾素血管紧张素系统功能
  • 批准号:
    8381682
  • 财政年份:
    2005
  • 资助金额:
    $ 14.92万
  • 项目类别:
Antenatal Steroid Exposure and Neural Control of Blood Pressure
产前类固醇暴露与血压的神经控制
  • 批准号:
    8381684
  • 财政年份:
    2005
  • 资助金额:
    $ 14.92万
  • 项目类别:
Antenatal Steroids and Cardiometabolic Risk
产前类固醇和心脏代谢风险
  • 批准号:
    8712519
  • 财政年份:
    2005
  • 资助金额:
    $ 14.92万
  • 项目类别:
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin
产前类固醇暴露对肾内肾素-血管紧张素的影响
  • 批准号:
    9264075
  • 财政年份:
    2005
  • 资助金额:
    $ 14.92万
  • 项目类别:
The Impact of Antenatal Steroid Exposure on the Intrarenal Renin-Angiotensin
产前类固醇暴露对肾内肾素-血管紧张素的影响
  • 批准号:
    8918005
  • 财政年份:
    2005
  • 资助金额:
    $ 14.92万
  • 项目类别:
Critique of the Overall Program Project Application
总体方案立项申请评审
  • 批准号:
    7012101
  • 财政年份:
    2005
  • 资助金额:
    $ 14.92万
  • 项目类别:
Antenatal Steroids and Cardiometabolic Risk
产前类固醇和心脏代谢风险
  • 批准号:
    8381685
  • 财政年份:
    2005
  • 资助金额:
    $ 14.92万
  • 项目类别:
ANIMAL CORE
动物核心
  • 批准号:
    8381688
  • 财政年份:
    2005
  • 资助金额:
    $ 14.92万
  • 项目类别:
Prenatal Events-Postnatal Consequences
产前事件-产后后果
  • 批准号:
    8712515
  • 财政年份:
    2005
  • 资助金额:
    $ 14.92万
  • 项目类别:

相似国自然基金

心包脂肪组织特异性调节性T细胞在急性心肌梗死后心室重塑中的作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
心包脂肪组织特异性调节性T细胞在急性心肌梗死后心室重塑中的作用及机制研究
  • 批准号:
    82270285
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
基于PET/CT分子影像研究心外膜脂肪组织炎症反应对急性心肌梗死心肌炎症及左室重构的作用和机制
  • 批准号:
    82272031
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
骨髓脂肪组织分泌肽BMATP2克服急性髓系白血病蒽环类药物耐药性的作用机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

Role of Interferon-Gamma / Interleukin-12 Axis in Metabolic Liver Disease
干扰素-γ/白介素-12 轴在代谢性肝病中的作用
  • 批准号:
    10735419
  • 财政年份:
    2023
  • 资助金额:
    $ 14.92万
  • 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
  • 批准号:
    10813753
  • 财政年份:
    2023
  • 资助金额:
    $ 14.92万
  • 项目类别:
Exercise Response in Humans with Obesity
肥胖症患者的运动反应
  • 批准号:
    10659320
  • 财政年份:
    2023
  • 资助金额:
    $ 14.92万
  • 项目类别:
Development of a Dedicated Fluidjet Technology for Single-session Debridement of Necrotizing Pancreatitis
开发用于坏死性胰腺炎单次清创的专用流体喷射技术
  • 批准号:
    10699626
  • 财政年份:
    2023
  • 资助金额:
    $ 14.92万
  • 项目类别:
Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.
优化小分子力学模拟治疗与年龄相关的骨质疏松症。
  • 批准号:
    10807685
  • 财政年份:
    2023
  • 资助金额:
    $ 14.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了